Viyash Scientific Limited Allots Over 20 Lakh Equity Shares Under SeQuent ESOP 2020
Viyash Scientific Limited announced the approval for the allotment of equity shares under its SeQuent Employee Stock Option Plan 2020 (ESOP). The move will increase the company's issued and paid-up equity share capital.The Nomination and Remuneration Committee of Viyash Scientific, which passed a resolution on July 31, 2026, approved the allotment of 20,01,336 Equity Shares. These shares were granted to eligible optionees at an exercise price of Rs. 86 per equity share, and they are issued with a face value of Rs. 2 each.
The newly allotted Equity shares will rank pari passu in all respects with the existing equity shares of the Company.
Capital Structure Changes
Consequent to this allotment, the company's capital structure saw a defined increase. The issuance of these options contributed to an increase in both the total number and the value of the issued and paid-up equity share capital.The financial details before and after the allotment are as follows:
| Financial Metric | Before Allotment | After Allotment |
|---|---|---|
| Total Issued & Paid-Up Capital | Rs. 87,37,50,954 /- | Rs. 87,77,53,626 /- |
| Number of Equity Shares (Rs. 2 each) | 43,68,75,477 | 43,88,76,813 |
The allotment was approved by the committee and is set to strengthen the capital base as the company progresses under the SeQuent ESOP 2020.
VIYASH Stock Price Movement
On Friday, shares of Viyash Scientific Limited edged higher, settling at ₹252 after climbing 0.14% on a marginal gain of ₹0.35 per share. The stock traded within a narrow intraday range during the session, hitting a low of ₹249.05 and peaking at ₹254.6.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.